In addition, such a molecule would also activate NF‐κB in malignant or premalignant cells, which might prove detrimental; for example, Nfkb1−/− mice exposed to a chemical mutagen have accelerated development of hepatocellular carcinoma [30]. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.